Illumina NextSequencing 500 System

The Department of Veterans Affairs,WJB Dorn VA Medical Center R&D Service intends to negotiate on a sole source basis with the Illumina Inc., pursuant to FAR 6.302-3; for the procurement of NextSeqâ„¢ 500 Sequencing System, an integrated system for automated generation of DNA clonal clusters by bridge amplification, sequencing, and primary analysis. System includes embedded touchscreen monitor and on-instrument computer, NextSeq Control Software, installation and training, and 12 months warranty (including parts and labor). This is a microscopic imaging system designed perform real-time, in vivo longitudinal analyses in animal models of pathology that are highly relevant to the mission of the VA, including neuropsychiatric disorders like post-traumatic stress disorder (PTSD) and depressive illness, cardiovascular disease and heart failure, obesity, multiple sclerosis, and cancer. This notice of intent is not a request for competitive proposals; however, any responsible source who believes it is capable of meeting the requirement may submit a capability statement to the contracting office no later than Wednesday, October 28, 2015, 4:00, EST. Interest/capability statements may be sent to Elaine DiBucci at elaine.dibucci@va.gov. No telephone responses will be accepted. A determination not to compete the proposed requirement based upon the responses to this notice is solely within the discretion of the Government